FR2250521A1 - - Google Patents

Info

Publication number
FR2250521A1
FR2250521A1 FR7437192A FR7437192A FR2250521A1 FR 2250521 A1 FR2250521 A1 FR 2250521A1 FR 7437192 A FR7437192 A FR 7437192A FR 7437192 A FR7437192 A FR 7437192A FR 2250521 A1 FR2250521 A1 FR 2250521A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7437192A
Other languages
French (fr)
Other versions
FR2250521B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Akzo NV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of FR2250521A1 publication Critical patent/FR2250521A1/fr
Application granted granted Critical
Publication of FR2250521B1 publication Critical patent/FR2250521B1/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/155Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16Compounds containing any of the groups, e.g. aminoguanidine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7437192A 1973-11-09 1974-11-08 Expired FR2250521B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7315350A NL7315350A (nl) 1973-11-09 1973-11-09 Nieuwe aminoguanidine verbindingen.

Publications (2)

Publication Number Publication Date
FR2250521A1 true FR2250521A1 (enExample) 1975-06-06
FR2250521B1 FR2250521B1 (enExample) 1979-03-16

Family

ID=19819967

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7437192A Expired FR2250521B1 (enExample) 1973-11-09 1974-11-08

Country Status (17)

Country Link
US (1) US3972932A (enExample)
JP (1) JPS5546389B2 (enExample)
AR (1) AR205358A1 (enExample)
BE (1) BE822019A (enExample)
CA (1) CA1032962A (enExample)
CH (1) CH616656A5 (enExample)
DE (1) DE2452691A1 (enExample)
DK (1) DK138791B (enExample)
ES (1) ES431775A1 (enExample)
FI (1) FI62064C (enExample)
FR (1) FR2250521B1 (enExample)
GB (1) GB1487852A (enExample)
HU (1) HU171856B (enExample)
IE (1) IE40409B1 (enExample)
NL (1) NL7315350A (enExample)
SE (1) SE420720B (enExample)
ZA (1) ZA746701B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141992A (en) * 1975-08-22 1979-02-27 American Cyanamid Company Cycloalkylcarboxyamidines and halobenzamidines as anti-amebic agents
US4113776A (en) * 1976-04-15 1978-09-12 Hoffmann-La Roche Inc. 1-(2-Aminoethyl)-3-(2,6-dihalophenyl)guanidines
HU190639B (en) * 1983-12-12 1986-09-29 Gyogyszerkutato Intezet Kv,Hu Process for production of new aminoguanidin derivatives
ZA857153B (en) * 1984-09-19 1986-05-28 Ciba Geigy Ag Substituted carbodiimides
ATE59633T1 (de) * 1984-09-19 1991-01-15 Ciba Geigy Ag Substituierte carbodiimide.
ZA911553B (en) 1990-03-02 1991-12-24 Oregon State Tri-and tetra-substituted guanidines and their use as excitatory amino acid and antagonists
US5262568A (en) * 1990-03-02 1993-11-16 State Of Oregon Tri- and tetra-substituted guanidines and their use as excitatory amino acid antagonists
US5847006A (en) * 1991-02-08 1998-12-08 Cambridge Neuroscience, Inc. Therapeutic guanidines
EP0940139B1 (en) * 1991-02-08 2005-02-02 Scion Pharmaceuticals, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
US5741661A (en) * 1991-02-08 1998-04-21 Cambridge Neuroscience, Inc. Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
EP0705100B1 (en) * 1993-05-27 2003-07-30 CeNes Limited Therapeutic substituted guanidines
KR100424523B1 (ko) * 1993-11-23 2004-09-30 캠브리지 뉴로사이언스, 인코포레이티드 치료용의치환된구아니딘
US6787569B1 (en) 1994-02-03 2004-09-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
US6143791A (en) * 1994-02-03 2000-11-07 Cambridge Neuroscience, Inc. Therapeutic guanidines
KR100423272B1 (ko) 1994-02-03 2004-09-01 캠브리지 뉴로사이언스, 인코포레이티드 신경전달물질의방출을조절하는화합물,이의약학적으로허용가능한염및이를포함하는약학조성물
US7351743B1 (en) 1994-02-03 2008-04-01 Wyeth Therapeutic guanidines
JP4739695B2 (ja) * 2004-06-07 2011-08-03 株式会社日本ファインケム 5−アミノ―1―置換―1,2,4―トリアゾールの製造方法、及び該製造方法で得られるトリアゾール誘導体
JP4564786B2 (ja) * 2004-06-07 2010-10-20 株式会社日本ファインケム 1−置換―1―アミノグアニジン又はその塩、及びこれらの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB800869A (en) * 1955-09-28 1958-09-03 Ici Ltd Substituted amino-guanidines
NL7011683A (enExample) * 1970-08-07 1972-02-09

Also Published As

Publication number Publication date
ZA746701B (en) 1975-11-26
AR205358A1 (es) 1976-04-30
FI62064C (fi) 1982-11-10
GB1487852A (en) 1977-10-05
JPS5077328A (enExample) 1975-06-24
FR2250521B1 (enExample) 1979-03-16
DK138791B (da) 1978-10-30
CA1032962A (en) 1978-06-13
DK138791C (enExample) 1979-04-09
US3972932A (en) 1976-08-03
FI62064B (fi) 1982-07-30
DK579774A (enExample) 1975-07-07
BE822019A (fr) 1975-05-09
NL7315350A (nl) 1975-05-13
CH616656A5 (enExample) 1980-04-15
IE40409L (en) 1975-05-09
SE7414045L (enExample) 1975-05-12
IE40409B1 (en) 1979-05-23
SE420720B (sv) 1981-10-26
HU171856B (hu) 1978-04-28
ES431775A1 (es) 1976-12-16
FI324374A7 (enExample) 1975-05-10
DE2452691A1 (de) 1975-05-15
JPS5546389B2 (enExample) 1980-11-22

Similar Documents

Publication Publication Date Title
AR201758A1 (enExample)
AU476761B2 (enExample)
AU465372B2 (enExample)
AR201235Q (enExample)
AR201231Q (enExample)
AU474593B2 (enExample)
AU474838B2 (enExample)
DK579774A (enExample)
AU465453B2 (enExample)
AU471343B2 (enExample)
AU465434B2 (enExample)
AU450229B2 (enExample)
AU476714B2 (enExample)
AR201229Q (enExample)
AU466283B2 (enExample)
AR199451A1 (enExample)
AU476696B2 (enExample)
AU472848B2 (enExample)
AU477823B2 (enExample)
AR197627A1 (enExample)
AU476873B1 (enExample)
AR200256A1 (enExample)
AU461342B2 (enExample)
AR210729A1 (enExample)
AU477824B2 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse